What is ATRC's health score?

AtriCure, Inc. (ATRC) has a TradeApes health score of 66 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ATRC's estimated fair value?

Based on our 5-year discounted cash flow model, AtriCure, Inc.'s estimated fair value is $25.19 per share, representing a -6.1% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is ATRC undervalued or overvalued?

Our model currently rates ATRC as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ATRC... Refresh in a moment for the full analysis.

AtriCure, Inc. (ATRC)

Healthcare Fair Value low healthy

$26.84

Updated: 2026-06-04

TradeApes Score

Financial Strength

70 Healthy

Operating Trend

66 Healthy

Relative Value

75 Strong

Capital Allocation

35 Weak

Risk

80 Strong

Est. Fair Value $25.19

DCF Upside -6.1%

Sector Rank #303 of 6609

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.